RxDoctor Payments Data

Heather Hunley

Family · Tazewell, TNNPI 1689174211

Payments from drug & device makers

$3,267in general payments, 2019–2025

Across 234 payments — averaging $13.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$938
  • Novo Nordisk$560
  • AstraZeneca$283
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$266
  • Amarin Pharma, Inc.$221
  • Biohaven Pharmaceutical Holding Company Ltd.$134
  • plus $865 from 16 others

What the payments were for

  • Food & beverage$3,267100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,267 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide76$109,291
FarxigaDapagliflozin Propanediol122$103,996
Breztri AerosphereBudesonide/Glycopyr/Formoterol70$55,510
Tresiba Flextouch U-200Insulin Degludec21$42,396
EliquisApixaban46$39,494
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$38,501
MounjaroTirzepatide34$35,226
VascepaIcosapent Ethyl43$23,672
LinzessLinaclotide21$21,082
VraylarCariprazine Hcl11$15,194
Soliqua 100-33Insulin Glargine/Lixisenatide15$13,660
BrilintaTicagrelor11$6,780
SymbicortBudesonide/Formoterol Fumarate22$5,685
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$5,637
Albuterol Sulfate HfaAlbuterol Sulfate159$4,505

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$283$171,971225 claims
Novo NordiskOzempic$560$109,29176 claims
PfizerEliquis$89$39,49446 claims
GSKTrelegy Ellipta$103$38,50145 claims
AbbVieLinzess, Vraylar$938$36,27632 claims
Lilly USA, LLCMounjaro$50$35,22634 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Tazewell

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →